Alcouffe; Chantal

Patent Applications and Registrations

Patent applications and USPTO patent grants for Alcouffe; Chantal.The latest application filed is for "pyrazolopyridine derivatives, preparation process therefor and therapeutic use thereof".

Company Profile

0.12.13

Alcouffe; Chantal - Paris FR
ALCOUFFE; Chantal - US
Alcouffe; Chantal - Roquettes N/A FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pyrazolopyridine derivatives, preparation process therefor and therapeutic use thereof Grant 10,138,235 - Alcouffe , et al. Nov	2018-11-27
Pyrazolopyridine Derivatives, Preparation Process Therefor And Therapeutic Use Thereof App 20170231998 - ALCOUFFE; Chantal ; et al.	2017-08-17
Therapeutic use of imidazopyridine derivatives Grant 9,732,078 - Alcouffe , et al. August 15, 2	2017-08-15
Pyrazolopyridine Derivatives, Preparation Process Therefor And Therapeutic Use Thereof App 20170174681 - ALCOUFFE; Chantal ; et al.	2017-06-22
Pyrazolopyridine derivatives for use in the treatment of bladder cancer Grant 9,572,799 - Alcouffe February 21, 2	2017-02-21
Imidazopyridine derivatives, process for preparation thereof and therapeutic use thereof Grant 9,452,164 - Alcouffe , et al. September 27, 2	2016-09-27
Pyrazolopyridine Derivatives For Use In The Treatment Of Bladder Cancer App 20160128989 - ALCOUFFE; Chantal	2016-05-12
Pyrazolopyridine Derivatives, Preparation Process Therefor And Therapeutic Use Thereof App 20140350006 - Alcouffe; Chantal ; et al.	2014-11-27
Therapeutic Use of Imidazopyridine Derivatives App 20140343054 - Alcouffe; Chantal ; et al.	2014-11-20
Indolizine derivatives, process for the preparation thereof and therapeutic use thereof Grant 8,859,544 - Alcouffe , et al. October 14, 2	2014-10-14
Imidazopyridine Derivatives, Process For Preparation Thereof And Therapeutic Use Thereof App 20140243328 - ALCOUFFE; Chantal ; et al.	2014-08-28
Imidazopyridine derivatives, process for preparation thereof and therapeutic use thereof Grant 8,759,344 - Alcouffe , et al. June 24, 2	2014-06-24
Imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same Grant 8,633,216 - Alcouffe , et al. January 21, 2	2014-01-21
Imidazopyridine Derivatives, Process For Preparation Thereof And Therapeutic Use Thereof App 20130116250 - Alcouffe; Chantal ; et al.	2013-05-09
Indolizine Derivatives, Process For The Preparation Thereof And Therapeutic Use Thereof App 20130116249 - Alcouffe; Chantal ; et al.	2013-05-09
Imidazo[1,5-a] pyridine derivatives, method for preparing same and pharmaceutical compositions containing same Grant 8,008,321 - Alcouffe , et al. August 30, 2	2011-08-30
Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same App 20110136856 - ALCOUFFE; Chantal ; et al.	2011-06-09
Substituted indolizine 1,2,3,6,7,8 derivatives, FGFs inhibitors, a method for the preparation thereof and pharmaceutical compositions containing said derivatives Grant 7,553,845 - Alcouffe , et al. June 30, 2	2009-06-30
Novel imidazo[1,5-a] pyridine derivatives, method for preparing same and pharmaceutical compositions containing same App 20080108648 - ALCOUFFE; Chantal ; et al.	2008-05-08
Substituted indolizine 1,2,3,6,7,8 derivatives, FGFs inhibitors, a method for the preparation thereof and pharmaceutical compositions containing said derivatives App 20060199962 - Alcouffe; Chantal ; et al.	2006-09-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.